PULMONARY THROMBOEMBOLISM FOLLOWING RADIOFREQUENCY
ABLATION OF THE ATRIOVENTRICULAR
NODE IN A PATIENT HETEROZYGOUS FOR THE FACTOR
V LEIDEN AND THE MTHFR C677T MUTATIONS
Pešut DP1,2*, Raljević SV2, Kontić MDj2, Božić DZ2, Buha IB2, Stević RS1,3
*Corresponding Author: Dragica P. Pešut, School of Medicine University of Belgrade; Clinical Centre of
Serbia, Institute of Lung Diseases and Tuberculosis, Research and Epidemiology Department, 11000 Belgrade,
Visegradska 26/20, Serbia; Tel.: +381-11-361-5561; Fax: +381-11-268-1591;
E-mail: dragica. pesut@gmail.com
page: 51
|
|
REFERENCES
1. Tapson VF. Acute pulmonary embolism. N Engl J Med.
2008; 358(10): 1037-1052.
2. Rosendaal FR. Venous thrombosis: the role of genes,
environment, and behavior. Hematol Am Soc Hematol
Educ Program. 2005:1-12.
3. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma
PH. High risk of thrombosis in patients homozygous for
factor V Leiden (activated protein C resistance). Blood
1995; 85(6): 1504-1508.
4. Zöller B, García de Frutos P, Hillarp A, Dahlbäck B.
Thrombophilia as a multigenic disease. Haematologica.
1999; 84(1):59-70.
5. Djordjevic V, Rakicevic L, Gagic M, Nikolic A, Savic
A. Simultaneous detection of factor V Leiden and factor
II G20210A variants by a multiplex PCR on whole
blood. Balkan J Med Genet. 2001; 4(1&2): 15-17.
6. Djordjevic V, Stankovic M, Nikolic A, Antonijevic N,
Rakicevic LJ, Divac A, Radojkovic M. PCR amplification
on whole blood samples treated with different
commonly used anticoagulants. Pediatr Hematol Oncol.
2006; 23(6): 517-521.
7. Koebe J, Kirchhof P. Novel non-pharmacological approaches
for antiarrhythmic therapy of atrial fibrillation.
Europace. 2008; 10(4): 433-437.
8. Papagiannis J, Papadopoulou K, Rammos S, Demosthenes
Katritsis D. Cryoablation versus radiofrequency
ablation for atrioventricular nodal reentrant tachycardia
in children: long-term results. Hellenic J Cardiol. 2010;
51(2): 122-126.
9. Lin JL, Stephen Huang SK, Lai LP, Ko WC, Tseng YZ,
Lien WP. Clinical and electrophysiologic characteristics
and long-term efficacy of slow-pathway catheter
ablation in patients with spontaneous supraventricular
tachycardia and dual atrioventricular node pathways
without inducible tachycardia. J Am Coll Cardiol. 1998;
31(4): 855-860.
10. O’Hara GE, Philippon F, Champagne J, Blier L, Molin
F, Côté JM, Nault I, Sarrazin JF, Gilbert M. Catheter ablation
for cardiac arrhythmias: a 14-year experience with
5330 consecutive patients at the Quebec Heart Institute,
Laval Hospital. Can J Cardiol. 2007; 23(Suppl B): 67B-
70B. (Erratum: Can J Cardiol. 2009; 25(3): 140.)
11. Mansourati J, Deharo JC, Graux P, Chappuis L, Durieu
C, Dutoit A, Guillo P, Djiane P, Blanc JJ. Short and medium-
term outcome after radiofrequency ablation of the
atrioventricular junction. Arch Mal Coeur Vaiss. 1997;
90(7): 945-951. [Article in French]
12. Darpö B, Walfridsson H, Aunes M, Bergfeldt L, Edvardsson
N, Linde C, Lurje L, van der Linden M, Rosenqvist
M. Incidence of sudden death after radiofrequency ablation
of the atrioventricular junction for atrial fibrillation.
Am J Cardiol. 1997; 80(9): 1174-1177.
13. Haman L, Parízek P, alý R, Duda J, Malý J. Analysis of
thrombotic complications after catheter ablation. Acta
Medica (Hradec Kralove). 2006; 49(1): 47-50.
14. Aznar J, Vaya A, Estelles A, Mira Y, Segui R, Villa
P, Ferrando F, Falco C, Corella D, Espana F. Risk of
venous thrombosis in carriers of the prothrombin
G20210A variant and factor V Leiden and their interaction
with oral contraceptives. Haematologica. 2000;
85(12): 1271-1276.
15. Coen D, Zadro R, Honovic L, Banfic L, Stavljenic Rukavina
A. Prevalence and association of the factor V
Leiden and prothrombin G20210A in healthy subjects
and patients with venous thromboembolism. Croat Med
J. 2001; 42(4): 488-492.
16. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke
JP, Bertina RM. Venous thrombosis due to
a poor anticoagulant response to activated protein C:
Leiden Thrombophilia Study. Lancet. 1993; 342(8886-
8887): 1503-1506.
17. Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik
R, Rosenberg N, Berliner S, Inbal A, Many A, Lubetsky
A, Varon D, Martinowitz U, Seligsohn U. Single and
combined prothrombotic factors in patients with idiopathic
venous thromboembolism: prevalence and risk
assessment. Arterioscler Thromb Vasc Biol. 1999;
19(3): 511-518.
18. Mandala M, Curigliano G, Bucciarelli P, Ferretti G,
Mannucci PM, Colleoni M, Ventura A, Peruzzotti G,
Severi G, Pelicci PG, Biffi R, Orsi F, Cinieri S, Goldhirsch
A. Factor V Leiden and G20210A prothrombin
mutation and the risk of subclavian vein thrombosis in
patients with breast cancer and a central venous catheter.
Ann Oncol. 2004; 15(4): 590-593.
19. Almawi WY, Tamim H, Kreidy R, Timson G, Rahal
E, Nabulsi M, Finan RR, Irani-Hakime N. A case control
study on the contribution of factor V-Leiden, prothrombin
G20210A, and MTHFR C677T mutations to
the genetic susceptibility of deep venous thrombosis. J
Thromb Thrombolysis. 2005; 19(3): 189-196.
20. Makris M, Preston FE, Beauchamp NJ, Cooper PC,
Daly ME, Hampton KK, Bayliss P, Peake IR, Miller GJ.
Co-inheritance of the 20210A allele of the prothrombin
gene increases the risk of thrombosis in subjects with
familial thrombophilia. Thromb Haemost. 1997; 78(6):
1426-1429.
21. Howard TE, Marusa M, Boisza J, Young A, Sequeira
J, Channell C, Guy C, Benson E, Duncan A. The prothrombin
gene 3’-untranslated region mutation is frequently
associated with factor V Leiden in thrombophilic patients and shows ethnic-specific variation in
allele frequency. Blood. 1998; 91(3):1092-1093.
22. Cattaneo M, Tsai MY, Bucciarelli P, Taioli E, Zighetti
ML, Bignell M, Mannucci PM. A common mutation in
the methylenetetrahydrofolate reductase gene (C677T)
increases the risk for deep vein thrombosis in patients
with mutant factor V (factor V:Q506). Arterioscler
Thromb Vasc Biol. 1997; 17(9): 1662-1666.
23. Nagorni-Obradovic Lj, Miljic P, Djordjevic V, Pesut D,
Jovanovic D, Stojsic J, Stevic R, Radojkovic D. The prothrombin
factor II G20210A mutation with pulmonary
thromboembolism and a normal level of fibrin degradating
products. Balkan J Med Genet. 2009; 12(2): 69-76.
24. Yamamoto T, Ito M, Nagata S, Suzuki H, Tagawa A,
Nagase M, Hishida AJ. Catastrophic exacerbation of
antiphospholipid syndrome after lung adenocarcinoma
biopsy. J Rheumatol. 2000; 27(8): 2035-2037.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
